Innovating Works

QBIO

Desconocido
PRECISESADS: Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases Quartz Bio S.A. participó en un FP7: We concur to the IMI on Reclassification of SLE, connective tissue diseases and RA call by presenting a proposal aimed at using the power of...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.